5 ESSENTIAL ELEMENTS FOR AGO TUMOR

Hormonal therapy continues to be the remedy of first choice for metastatic patients with endocrine-responsive breast cancer (LoE 1a A, AGO ++). The sequential use from the offered medication depends on the person pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at some time of diagnosis of relapse is recommended When feasible, in an e